Basic & Clinical Pharmacology & Toxicology

Papers
(The H4-Index of Basic & Clinical Pharmacology & Toxicology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Issue Information263
219
123
Incidence in pharmacoepidemiology—Basic definitions and types of misclassification64
Matrix metalloproteinases are associated with severity of disease among COVID‐19 patients: A possible pharmacological target58
Copper fabric improves the metabolic profile of obese mice: Potential role of the gut microbiota58
How does deprescribing (not) reduce mortality? A review of a meta‐analysis in community‐dwelling older adults casts uncertainty over claimed benefits37
Issue Information30
Efficacy of fibroblast growth factor 21 in non‐alcoholic fatty liver disease in guinea pigs24
A two‐decade review of butane toxicity as a substance of abuse24
23
Lithium and the risk of chronic kidney disease: A population‐based case–control study23
Electrochemical Point‐of‐Care Test for Assessing Serum Paracetamol Concentration: Comparison With Traditional Methods and Detection of Concomitant Drugs21
Register‐based study on prescription renewal without the prescriber meeting the patient21
Issue Information20
The Pharmacokinetics, Pharmacological Mechanisms and Clinical Application of Zhenwu Decoction20
Barriers and Facilitators to Pharmacist‐Led Deprescribing of Antihypertensives in Long‐Term Care: A Survey‐Based Study19
Antioxidant, Antiinflammatory and Antiapoptotic Effects of Lycopene in Rats With Vancomycin‐Induced Nephrotoxicity19
Artesunate alleviates intracerebral haemorrhage secondary injury by inducing ferroptosis in M1‐polarized microglia and suppressing inflammation through AMPK/mTORC1/GPX4 pathway18
Medication use among the oldest old in the Faroe Islands—A national cross‐sectional study18
Patients' Attitudes Towards Deprescribing Differ Across Specific Cardiovascular and Diabetes Medication: A Survey Study Assessing Within‐Patient Differences18
Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction18
18
0.1368420124054